News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Jazz Pharmaceuticals plc (JAZZ) Announces First Quarter 2013 Financial Results


5/8/2013 6:45:05 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, May 7, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced financial results for the first quarter ended March 31, 2013, updated 2013 financial guidance and key additions to its board of directors.

"During the first quarter, we continued to deliver strong top and bottom line growth fueled by growing sales of Xyrem and Erwinaze," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals plc.

Help employers find you! Check out all the jobs and post your resume.

Read at Yahoo Finance


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES